Early change in tumor size from waterfall plot analysis and RECIST response as predictor of overall survival (OS) in advanced, chemotherapy-refractory colorectal cancer (ACRC): NCIC CTG/AGITG CO.17 study
| Autor: | John Simes, A. H. Strickland, Chris Karapetis, Desmond Yip, Anna Tomiak, Derek J. Jonker, John Zalcberg, Timothy J. Price, Michael Jefford, Dongsheng Tu, Matthew Links, S. K. Yadav, Margot J. Burnell, G. Van Hazel, Christopher J. O'Callaghan, M. Taylor, Niall C. Tebbutt |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Chemotherapy Cetuximab Tumor size business.industry Colorectal cancer medicine.medical_treatment Waterfall plot medicine.disease digestive system diseases Surgery Refractory Internal medicine medicine Overall survival In patient business neoplasms medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 29:3602-3602 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | 3602 Background: The CO.17 trial demonstrated that the addition of cetuximab monotherapy (C) to best supportive care (BSC) improves OS and progression-free survival (PFS) in patients (pts) with ACR... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|